Loading…
Wednesday, June 28 • 1:15pm - 2:15pm
Regulatory Insights into Decentralized Clinical Trials

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Component Type: Session
Level: Basic

The COVID-19 pandemic improved the acknowledgement and concept of decentralized clinical trials (DCT). We will share our guidance on conducting clinical trials during COVID-19 pandemic and our insights into decentralized clinical trial.

Learning Objectives

Describe the regulatory insights into decentralized clinical trial; Discuss the Asian experience of decentralized clinical trial and digital tools use in the trial.

Chair

Hsin-Jung Chuang, MS, RPh


Speakers
avatar for Hsin-Jung Chuang

Hsin-Jung Chuang

Associate Reviewer, TFDA, Taiwan
Ms. Hsin-Jung Chuang holds a master's degree in pharmacy from China Medical University and is currently involved in the regulatory review of investigational new drugs (INDs). Her responsibilities include evaluating INDs for compliance with regulatory standards. Additionally, she participates... Read More →


Wednesday June 28, 2023 1:15pm - 2:15pm CDT
TBD Boston Convention and Exhibition Center 415 Summer Street, Boston, MA 02210 USA